Successful control with carbamazepine of family with paroxysmal kinesigenic dyskinesia of PRRT2 mutation

BioMedicine (Taiwan)

Volumn 4, Issue 2, 2014, Pages 51-53

  Chou, I Ching ^a,b   Lin, Sheng Shing ^a   Lin, Wei De ^c   Wang, Chung Hsing ^a   Chang, Yu Tzu ^a   Tsai, Fuu Jen ^a,c   Tsai, Chang Hai ^a,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

Carbamazepine; Mutation; Paroxysmal dyskinesia; PRRT2

Indexed keywords

CARBAMAZEPINE; MEMBRANE PROTEIN; PROLINE RICH PROTEIN; PROLINE RICH TRANSMEMBRANE PROTEIN 2; UNCLASSIFIED DRUG;

ARM MOVEMENT; ARTICLE; CASE REPORT; CHILD; ELECTROENCEPHALOGRAM; FRAMESHIFT MUTATION; GENE IDENTIFICATION; HUMAN; JOINT MOBILITY; LABORATORY TEST; LOW DRUG DOSE; MALE; MISSENSE MUTATION; MONOTHERAPY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROXYSMAL KINESIGENIC DYSKINESIA; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE;

EID: 84939133790     PISSN: 22118020     EISSN: 22118039     Source Type: Journal    
DOI: 10.7603/s40681-014-0015-0     Document Type: Article

References (23)

1. Houser MK, Soland VL, Bhatia KP, Quinn NP, Marsden CD. Paroxysmal inesigenic choreoathetosis: a report of 26 patients. J Neurol 1999; 246:120-26.
2. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995; 38:571-79.
3. Bhatia KP. The paroxysmal dyskinesias. J Neurol 1999; 246:149-55.
4. Nagamitsu S, Matsuishi T, Hashimoto K, et al. Multicenter study of paroxysmal dyskinesias in Japan: clinical and pedigree analysis. Mov Disord 1999; 4:658-63.
5. Zorzi G, Conti C, Erba A, Granata T, Angelini L, Nardocci N. Paroxysmal yskinesias in childhood. Pediatr Neurol 2003; 28:168-72.
6. Hwang WJ, Lu CS, Tsai JJ. Clinical manifestations of 20 Taiwanese patients with paroxysmal kinesigenic dyskinesia. Acta Neurol Scand 1998; 98:340-45.
7. Ohmori I, Ohtsuka Y, Ogino T, Yoshinaga H, Kobayashi K, Oka E. Relationship between paroxysmal kinesigenic choreoathetosis and epilepsy. Neuropediatrics 2002; 33:15-20.
8. Tan LC, Tan AK, Tjia H. Paroxysmal kinesigenic choreoathetosis in Singapore and its relationship to epilepsy. Clin Neurol Neurosurg 1998; 100:187-92.
9. Hirata K, Katayama S, Saito T, et al. Paroxysmal kinesigenic choreoathetosis with abnormal electroencephalogram during attacks. Epilepsia 1991; 32:492-94.
10. Ptacek LJ. Channelopathies: ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system. Neuromuscul Disord 1997; 7: 250-55.
11. Chen WJ, Lin Y, Xiong ZQ, Wei W, Ni W, et al. Exome sequencing dentifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic yskinesia. Nat Genet 2011; 43: 1252-55.
12. Wang JL, Cao L, Li XH, Hu ZM, Li JD, et al. Identification of PRRT2 asthe causative gene of paroxysmal kinesigenic dyskinesias. Brain 2012;134: 490-98.
13. Li J, Zhu X, Wang X, Sun W, Feng B, et al. Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis. J Med Genet 2012; 49: 76-78.
14. Lee HY, Huang Y, Bruneau N, Roll P, Roberson EDO, et al. Mutations in the novel protein PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsion. Cell Reports 2012; 1: 1-11.
15. Heron SE, Grinton BE, Kivity S, Afawi Z, Zuberi SM, et al. PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am J Hum Genet 2012; 90: 152-60.
16. Choi IS, Kim JH, Jung WY. Paroxysmal kinesigenic choreoathetosis. Yonsei Med J 1996; 37:68-71.
17. Ko CH, Kong CK, Ngai WT, Ma KM. Ictal (99m)Tc ECD SPECT in paroxysmal kinesigenic choreoathetosis. Pediatr Neurol 2001; 24:225-27.
18. Perlmutter JS, Raichle ME. Pure hemidystonia with basal ganglion abnormalities on positron emission tomography. Ann Neurol 1984; 15:228-33.
19. Hayashi R, Hanyu N, Yahikozawa H, Yanagisawa N. Ictal muscle discharge pattern and SPECT in paroxysmal kinesigenic choreoathetosis. Electromyogr Clin Neurophysiol 1997; 37:89-94.
20. Wein T, Andermann F, Silver K, Dubeau F, Andermann E, Rourke-Frew F, Keene D. Exquisite sensitivity of paroxysmal kinesigenic choreoathetosis to carbamazepine. Neurology 1996; 47:1104-06.
21. Gokcay A, Gokcay F. Oxcarbazepine therapy in paroxysmal kinesigenic choreoathetosis. Acta Neurol Scand 2000; 101:344-45.
22. Uberall MA, Wenzel D. Effectiveness of lamotrigine in children with paroxysmal kinesigenic choreoathetosis. Dev Med Child Neurol 2000; 42:699-700.
23. Liu Q, Qi Z, Wan XH, Li JY, Shi L, et al. Mutations in PRRT2 result in paroxysmal dyskinesias with marked variability in clinical expression. J Med Genet 2012; 49: 79-82.